Babies born with a narrowed blood vessel now have a device specifically designed for them, thanks to research conducted at ...

Translumina was incorporated in 2011 as a sales & marketing company specialising in coronary intervention devices. Since its ...

A study has found that sirolimus-coated balloons vs thin drug-eluting stents in in-stent restenosis show similar favorable clinical outcomes.

SpectraWAVE, the Massachusetts startup company whose technology combines two optical imaging techniques to aid treatment of ...

“Without dwelling on it three days later, I had a couple of stents put into one of my coronary arteries. I feel great. "I’ve ...

Without dwelling on it three days later, I had a couple of stents put into one of my coronary arteries. I feel great. I’ve ...

Summary: The use of balloon angioplasty with or without coronary artery stenting is limited by the phenomenon of in-stent restenosis (ISR). Until very recently, most efforts to overcome ISR had ...

Industrial Analysis of Coronary Stent in India value of over USD 1,213.5 million by 2033 anticipated expansion is supported ...

Michael Matson, an analyst from Needham, maintained the Buy rating on Merit Medical Systems (MMSI – Research Report). The associated ...

Navi Mumbai: A 46 year detected with a hole in heart - a complication seen mostly in children- has become the first person in ...

Translumina, established in 2011, focuses on coronary intervention devices and has expanded its manufacturing capabilities and product lines. The company aims to highlight Indian innovation in the ...